CCDC166 and breast cancer: To examine the clinical significance of CanCord34 overexpression in breast cancer patients, next, we performed a multivariate analysis of the CanCord34 genes using the Kaplan–Meier survival program, for which clinical data were available, except for data on CCDC166.